{"transactions":[{"id":947463,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70081,"kind":"person","name":"Seymour June Ann","position":1,"cik":"0002093716","reported_name":"Seymour June Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-06T16:18:53.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 2, 2027. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":19000,"derivative":{"exercise_price":6.76,"expiration_date":"2036-01-01","underlying":"Common  Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001453687-26-000034","document":"wk-form4_1767734330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2093716/000145368726000034/wk-form4_1767734330.xml","form_type":"4"}},{"id":947462,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70081,"kind":"person","name":"Seymour June Ann","position":1,"cik":"0002093716","reported_name":"Seymour June Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-01-06T16:18:53.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2027. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2030."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001453687-26-000034","document":"wk-form4_1767734330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093716/000145368726000034/wk-form4_1767734330.xml","form_type":"4"}},{"id":1012706,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":70081,"kind":"person","name":"Seymour June Ann","position":1,"cik":"0002093716","reported_name":"Seymour June Ann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-28T16:05:51.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% on October 27, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on October 27, 2029."}],"balance_after":50000,"derivative":{"exercise_price":8.85,"expiration_date":"2035-10-27","underlying":"Common  Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001453687-25-000112","document":"wk-form4_1761681948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2093716/000145368725000112/wk-form4_1761681948.xml","form_type":"4"}}]}